Fulgent Genetics, Inc. — Director's Dealing 2020

Aug 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-08-17

Reporting Person: BOLGER JOHN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-17	Common Stock	M	2631	$12.312	Acquired	5927	Direct
2020-08-17	Common Stock	S	3914	$40.8705	Disposed	2013	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-17	Stock Options (Right to Buy)	$12.312	M	2631	Disposed	2026-06-21	Common Stock (2631)	Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $40.72 to $41.03, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: The units subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after June 22, 2016, and 1/16th of such units vesting every three months over the remaining 36 months, subject to the reporting person's continued service for the Issuer on each vesting date.